Evaluation of platelet activation in canine immune-mediated haemolytic anaemia

Journal of Small Animal Practice

Volumn 51, Issue 6, 2010, Pages 296-304

  Ridyard, A E ^a   Shaw, D J ^a   Milne, E M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; CASE CONTROL STUDY; CYTOLOGY; DOG; DOG DISEASE; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE; MALE; METABOLISM; PHYSIOLOGY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM; VETERINARY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; LEUKOCYTES; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; RISK FACTORS; THROMBOCYTOPENIA; THROMBOEMBOLISM;

CANIS FAMILIARIS;

EID: 77954519813     PISSN: 00224510     EISSN: 17485827     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2010.00935.x     Document Type: Article

References (36)

1. Abrams C S, Ellison N, Budzynski A Z, Shattil S J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990, 75:128-138.
2. Barnard M R, Linden M D, Frelinger A L, Li Y, Fox M L, Furman M I, Michelson A D. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity. Journal of Thrombosis and Haemostasis 2005, 3:2563-2570.
3. Burgess K, Moore A, Rand W, Cotter S M. Treatment of immune-mediated haemolytic anaemia in dogs with cyclophosphamide. Journal of Veterinary Internal Medicine 2000, 14:456-462.
4. Carr A P, Panciera D L, Kidd L. Prognostic factors for mortality and thromboembolism in canine IMHA: a retrospective study of 72 dogs. Journal of Veterinary Internal Medicine 2002, 16:504-509.
5. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Platelet activation is increased in peripheral arterial disease. Journal of Vascular Surgery 2003, 38:99-103.
6. Chung T, Connor D, Joseph J, Emmett L, Mansberg R, Peters M, Kritharides D, Kritharides L. Platelet activation in acute pulmonary embolism. Journal of Thrombosis and Haemostasis 2007, 5:918-924.
7. Gerdsen F, Weber M, Langer F, Eifrig B, Lindhoff-Last E. Platelet activation markers in patients with venous thromboembolism without predisposing factors. Pathophysiology of Haemo-stasis and Thrombosis 2005, 24:1-5.
8. Green R A. Pathophysiology of antithrombin deficiency. Veterinary Clinics of North America:Small Animal Practice 1988, 18:95-104.
9. Holmes M B, Sobel B E, Howard D B, Schneider D J. Differences between activation thresholds for platelet p-selectin and glycoprotein IIb-IIIa expression and their clinical implications. Thrombosis Research 1999, 95:75-82.
10. Hugel B, Martínez M C, Kunzelmann C, Freyssinet J M. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005, 20:22-27.
11. Hughes M, Hayward C P, Warkentin T E, Horsewood P, Chorneyko K A, Kelton J G. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000, 96:188-194.
12. Li N. Platelet-lymphocyte cross-talk. Journal of Leukocyte Biology 2008, 83:1069-1078.
13. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocyte tissue factor expression. Arteriosclerosis Thrombosis and Vascular Biology 2000, 20:2322-2328.
14. McManus P M, Craig L E. Correlation between leucocytosis and necropsy findings in dogs with immune-mediated haemolytic anaemia: 34 cases (1994-1999). Journal of the American Veterinary Medical Association 2001, 218:1308-1313.
15. Michelson A D, Barnard M R, Krueger L A, Valeri C R, Furman M I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001, 104:1533-1537.
16. Mimidis K, Papadopoulos V, Kotsianidis J, Filippou D, Spanoudakis E, Bourikas G, Dervenis C, Kartalis G. Alterations of platelet function, number and indexes during acute pancreatitis. Pancreatology 2004, 4:22-27.
17. Mischke R. Haemostatic disorders as a complication of autoimmune haemolytic anaemia in dogs. Deutsche Tierärztliche Wochenschrift 1998, 105:13-16.
18. Moritz A, Walcheck B K, Weiss D J. Flow cytometric detection of activated platelets in the dog. Veterinary Clinical Pathology 2003, 32:6-12.
19. Nelson O L, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. Journal of Veterinary Internal Medicine 2003, 17:830-834.
20. Panzer S, Höcker L, Vormittag R, Rieger M, Koren D, Dunkler D, Pabinger I. Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia. Pediatric Blood and Cancer 2006, 47:694-696.
21. Perez-Pujol S, Marker P H, Key N S. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry Part A 2006, 71:38-45.
22. Piccin A, Murphy W G, Smith O P. Circulating microparticles: pathophysiology and clinical implications. Blood Reviews 2007, 21:157-171.
23. Ritchie J L, Alexander H D, Rea I M. Flow cytometry analysis of platelet P-selectin expression in whole blood - methodological considerations. Clinical and Laboratory Haema-tology 2000, 22:359-363.
24. Santos M T, Valles J, Marcus A J, Safier L B, Broekman M J, Islam N, Ullman H L, Eiroa A M, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. Journal of Clinical Investigation 1991, 87:571-580.
25. Schmitz G, Rothe G, Ruf A, Barlage S, Tschöpe D, Clemetson K J, Goodall A H, Michelson A D, Nurden A T, Shankey T V. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thrombosis and Haemostasis 1998, 79:885-896.
26. Scott-Moncrieff J C, Treadwell N G, McCullough S M, Brooks M B. Hemostatic abnormalities in dogs with primary immune-mediated haemolytic anemia. Journal of the American Animal Hospital Association 2001, 37:220-227.
27. Tarnow I, Kristensen A T, Krogh A K, Frelinger III A L, Barnard M R, Michelson A D. Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation. Veterinary Immunology and Immunopathology 2008, 123:345-352.
28. Valles J, Santos M T, Aznar J, Marcus A J, Martinez-Sales V, Portoles M, Broekman M J, Safier L B. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 1991, 78:154-162.
29. van der Zee P M, Biró E, Ko Y, de Winter R J, Hack C E, Sturk A, Nieuwland R. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clinical Chemistry 2006, 52:657-664.
30. Wagner D D, Burger P C. Platelets in inflammation and thrombosis. Arteriosclerosis, Thrombosis and Vascular Biology 2003, 23:2131-2137.
31. Warman S M, Murray J K, Ridyard A, Eastwood J, Silva S, Day M J. Pattern of Coombs test reactivity has diagnostic significance in dogs with immune-mediated haemolytic anaemia. Journal of Small Animal Practice 2008, 49:525-530.
32. Weinkle T K, Center S A, Randolph J F, Warner K L, Barr S C, Erb H N. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). Journal of the American Veterinary Medical Association 2005, 226:1869-1880.
33. Weiss D J, Brazzell J L. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. Journal of Veterinary Internal Medicine 2006, 20:682-686.
34. Wills T, Wardrop K, Meyers K. Detection of activated platelets in canine blood by use of flow cytometry. American Journal of Veterinary Research 2006, 67:56-63.
35. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anaemia. Journal of Laboratory Clinical Medicine 1997, 129:507-516.
36. Yngen M, Ostenson C-G, Hu H, Hjemdahl P, Wallen N H. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologica 2004, 47:537-540.